Amrize Ltd $AMRZ Stake Lessened by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. lessened its holdings in shares of Amrize Ltd (NYSE:AMRZ) by 4.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 357,735 shares of the company’s stock after selling 15,856 shares during the quarter. Sumitomo Mitsui Trust Group Inc. owned about 0.06% of Amrize worth $13,376,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in AMRZ. Amundi boosted its stake in Amrize by 30.9% in the 1st quarter. Amundi now owns 1,654,739 shares of the company’s stock worth $92,698,000 after purchasing an additional 390,750 shares during the period. DJE Kapital AG raised its position in shares of Amrize by 45.9% during the first quarter. DJE Kapital AG now owns 1,113,036 shares of the company’s stock valued at $60,194,000 after buying an additional 350,149 shares during the last quarter. Great Lakes Advisors LLC purchased a new position in shares of Amrize in the second quarter worth $16,975,000. Ancora Advisors LLC purchased a new position in shares of Amrize in the second quarter worth $15,112,000. Finally, Assetmark Inc. lifted its holdings in shares of Amrize by 18,567.2% in the first quarter. Assetmark Inc. now owns 250,887 shares of the company’s stock worth $14,055,000 after buying an additional 249,543 shares in the last quarter.

Analysts Set New Price Targets

Several equities analysts recently weighed in on AMRZ shares. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $60.00 target price on shares of Amrize in a research note on Monday, September 21st. Longbow Research assumed coverage on shares of Amrize in a research note on Monday, October 12th. They issued a “buy” rating on the stock. William Blair set a $40.00 price objective on shares of Amrize in a report on Wednesday, September 2nd. Zacks Research downgraded shares of Amrize from a “hold” rating to a “strong sell” rating in a report on Wednesday, August 19th. Finally, DA Davidson raised their price objective on Amrize from $40.00 to $43.00 and gave the company a “neutral” rating in a research report on Friday, October 30th. Eight research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $49.06.

Amrize Stock Down 3.4%

Shares of AMRZ opened at $42.63 on Friday. The stock has a market capitalization of $23.58 billion, a price-to-earnings ratio of 19.29, a price-to-earnings-growth ratio of 1.73 and a beta of 0.04. Amrize Ltd has a 1 year low of $35.78 and a 1 year high of $65.94. The business’s 50 day simple moving average is $39.57 and its 200-day simple moving average is $50.35. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67.

Amrize (NYSE:AMRZ) last announced its quarterly earnings results on Wednesday, October 28th. The company reported $1.05 earnings per share for the quarter, hitting the consensus estimate of $1.05. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The company had revenue of $3.77 billion for the quarter. During the same quarter in the prior year, the firm posted $0.98 EPS. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. As a group, equities analysts expect that Amrize Ltd will post 2.30 earnings per share for the current fiscal year.

Amrize Announces Dividend

The firm also recently announced a dividend, which will be paid on Wednesday, November 18th. Stockholders of record on Tuesday, November 10th will be issued a $0.11 dividend. The ex-dividend date is Tuesday, November 10th. Amrize’s payout ratio is 4.98%.

Insider Transactions at Amrize

In related news, insider Jaime Hill acquired 1,500 shares of Amrize stock in a transaction on Tuesday, August 11th. The shares were bought at an average cost of $47.12 per share, with a total value of $70,680.00. Following the completion of the purchase, the insider directly owned 29,698 shares of the company’s stock, valued at $1,399,369.76. The trade was a 5.32% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Baris Oran acquired 3,000 shares of Amrize stock in a transaction on Tuesday, August 11th. The shares were bought at an average cost of $47.38 per share, for a total transaction of $142,140.00. Following the completion of the purchase, the chief financial officer directly owned 3,000 shares of the company’s stock, valued at $142,140. The trade was a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders purchased 48,983 shares of company stock worth $2,158,755. 0.54% of the stock is currently owned by corporate insiders.

About Amrize

Amrize is a North American building-solutions company that supplies materials and products used in residential, commercial and infrastructure construction. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, roofing systems and other building products.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and related operations. Its products support applications ranging from roads, bridges and other public infrastructure to commercial buildings and residential construction.

Amrize was formed through the separation of Holcim’s North American business and began trading independently on the New York Stock Exchange under the symbol AMRZ in 2025.